| 479 | 5 | 77 |
| 下载次数 | 被引频次 | 阅读次数 |
促性腺激素释放激素激动剂(GnRH-a)作为体外受精-胚胎移植(IVF-ET)周期中促卵泡成熟的药物,能够明显减少卵巢过度刺激综合征(OHSS)的发生率。GnRH-a扳机后使用传统的雌、孕激素作为黄体支持方法会导致妊娠结局较差,但如果采用改良的黄体支持方案,则妊娠结局与传统人绒毛膜促性腺激素(HCG)扳机相似,同时又降低了OHSS的发生率。本文将对GnRH-a扳机后的黄体功能及其支持方案进行综述。
Abstract：The major advantage of triggering final oocyte maturation with a single bolus of GnRH agonist(GnRH-a)in IVF-ET cycles is the reduction in the occurrence of ovarian hyperstimulation syndrome(OHSS).Traditional luteal phase support in the form of progesterone and estradiol after GnRH-a trigger would lead to poor pregnancy outcome.Several recent studies reported that GnRH-a trigger combined with a modified luteal support regimen could achieve a reproductive outcome comparable to that after HCG triggering.This paper reviews the current status of the different approaches available for the luteal support after GnRH-a trigger.
[1]Humaidan P,Kol S,Papanikolaou EG.GnRH agonist for triggering of final oocyte maturation:time for a change of practice?[J].Hum Reprod Update,2011,17:510-524.
[2]Youssef MA,Van der Veen F,Al-Inany HG,et al.Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology[J/CD].Cochrane Database Syst Rev,2014,10:CD008046.
[3]Leth-Moller K,Hammer Jaqd S,Humaidan P.The luteal Phase after GnRH-a trigger-understanding an enigma[J].Int J Fertil Steril,2014,8:227-234.
[4]Humaidan P,Papanikolaou EG,Kyrou D,et al.The luteal phase after GnRH-agonist triggering of ovulation:present and future perspectives[J/OL].Reprod Biomed Online,2012,24:134-141.
[5]Griesinger G,Diedrich K,Devroey P,et al.GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol:a systematic review and meta-analysis[J].Hum Reprod Update,2006,12:159-168.
[6]Oktay K,Turkcuoglu I,Rodriguez-Wallberg KA.GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation[J/OL].Reprod Biomed Online,2010,20:783-788.
[7]Humaidan P,Bredkjaer HE,Bungum L,et al.GnRH agonist(buserelin)or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles:aprospective randomized study[J].Hum Reprod,2005,20:1213-1220.
[8]刁飞扬,王嫜,黄洁,等.拮抗剂方案中应用促性腺激素释放激素激动剂诱发卵母细胞成熟后不同黄体支持方案对妊娠结局的影响——一项提前终止的前瞻随机临床对照研究[J].生殖医学杂志,2013,22:797-801.
[9]Kolibianakis EM,Schultze-Mosgau A,Schroer A,et al.A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists[J].Hum Reprod,2005,20:2887-2892.
[10]Engmann L,DiLuigi A,Schmidt D,et al.The use of gonadotropin-releasing hormone(GnRH)agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome:aprospective randomized controlled study[J].Fertil Steril,2008,89:84-91.
[11] Imbar T,Kol S,Lossos F,et al.Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support[J].Hum Reprod,2012,27:753-759.
[12] Humaidan P,Engmann L,Benadiva C.Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer:the American versus European approaches[J].Fertil Steril,2015,103:879-885.
[13] Radesic B,Tremellen K.Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates[J].Hum Reprod,2011,26:3437-3442.
[14] Kol S,Humaidan P,Itskovitz-Eldor J.GnRH agonist ovulation trigger and hCG-based,progesterone-free luteal support:aproof of concept study[J].Hum Reprod,2011,26:2874-2877.
[15] Humaidan P,Bungum L,Bungum M,et al.Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist:apilot study[J/OL].Reprod Biomed Online,2006,13:173-178.
[16] Humaidan P,Ejdrup Bredkjaer H,Westergaard LG,et al.1,500IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasinghormone agonist is used for ovulation induction:a prospective,randomized,controlled study[J].Fertil Steril,2010,93:847-854.
[17] Humaidan P,Polyzos NP,Alsbjerg B,et al.GnRH-a trigger and individualized luteal phase hCG support according to ovarian response to stimulation:two prospective randomized controlled multi-centre studies in IVF patients[J].Hum Reprod,2013,28:2511-2521.
[18] Shapiro BS,Daneshmand ST,Garner FC,et al.Gonadotropinreleasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization[J].Fertil Steril,2008,90:231-233.
[19] Griffin D,Benadiva C,Kummer N,et al.Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders[J].Fertil Steril,2012,97:1316-1320.
[20] Papanikolaou EG,Verpoest W,Fatemi H,et al.A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering:a randomized prospective proof of concept study[J].Fertil Steril,2011,95:1174-1177.
基本信息:
中图分类号:R714.8
引用信息:
[1]刘思邈,邓成艳.IVF-ET拮抗剂方案中促性腺激素释放激素激动剂扳机后的黄体支持[J].生殖医学杂志,2015,24(11):965-968.
2015-11-15
2015-11-15